ReviewCurrent pharmaceutical design2026
Microbiota-Sensitive Nanocarriers for the Targeted Delivery of Therapeutic Agents into the Gut: Advanced Treatment Strategy for Inflammatory Bowel Disease.
Deepak Kumar et al.PubMed ↗Publisher ↗
No numbers read from the abstract.